Retraction
Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges
Paper Information
Record ID:
47357
Author(s):
Journal:
Publication Date:
August 20, 2021
Retraction Date:
September 04, 2023
(2.2 years years ago)
Subjects:
Institutions:
- Human Genetics Division, Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology (NIGEB), Tehran, Iran
- Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand
- Department of Physiology, College of Medicine, University of Suleimanyah, Suleimanyah, Iraq
- Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaimaniyah, Iraq
- Institute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russia
- Laboratory of Food Chemistry, Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow, Russia
- Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia
- Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt
- Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
- Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran
- Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States
- Toxicology and Chemotherapy Unit (G401), German Cancer Research Center, Heidelberg, Germany
Countries:
Article Type:
Publisher:
Frontiers
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3389/fimmu.2023.1285126Additional Notes:
see also: https://blog.frontiersin.org/2023/09/04/frontiers-implements-new-policy-to-counter-authorship-for-sale/
Citations (41)
41
Total Citations19
Post-Retraction(46.3%)
22
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
12
Within 1 year
0
After 2+ years
635
Days since retraction (latest)
Beyond TRAIL Resistance: Novel Strategies for Potentiating TRAIL-Induced Apoptosis in Cancer
Jitendra Gupta, Hussein Salim Abed, Subasini Uthirapathy et al. (10 authors)
Experimental Cell Research
Published: May 2025
635 days after retraction
Insights into novel inhibitory compounds against 14–3-3 Ε potential cancer therapeutic target through microscopic solvated dynamics
Alaa Abdulaziz Eisa
Journal of Molecular Liquids
Published: Apr 2025
575 days after retraction
Prognostic model for cervical cancer based on apoptosis-related genes
Lin Zhang, Shunjie Zheng, Pan Chen
Computer Methods in Biomechanics & Biomedical Engineering
Published: Feb 2025
541 days after retraction
Decoding oral cancer: insights from miRNA expression profiles and their regulatory targets
Xin Wang, Shuang Zhang, Shuyi Wang et al. (5 authors)
Frontiers in Molecular Biosciences
Open Access
Published: Jan 2025
1 citation
1 citation
512 days after retraction
Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells
Ke Wu, Xiaoxiao Ge, Xiaowei Duan et al. (10 authors)
Drug Resistance Updates
Published: Dec 2024
1 citation
1 citation
478 days after retraction
Immunogenic cell death: A new strategy to enhancing cancer immunotherapy
Lei Dou, Yu Fang, Huiyuan Yang et al. (5 authors)
Human Vaccines & Immunotherapeutics
Open Access
Published: Dec 2024
463 days after retraction
Pro-Inflammatory Activation Suppresses TRAIL-Induced Apoptosis of Acute Myeloid Leukemia Cells
M. I. Kobyakova, А. С. Сенотов, K. S. Krasnov et al. (12 authors)
Биохимия
Published: Sep 2024
376 days after retraction
Mechanism of probiotics in the intervention of colorectal cancer: a review
Qin‐Qin Li, Dongmei Liu, Minghua Liang et al. (6 authors)
World Journal of Microbiology and Biotechnology
Published: Aug 2024
3 citations
3 citations
351 days after retraction
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma
Giulia Grisendi, Massimiliano Dall’Ora, Giulia Casari et al. (28 authors)
Cell Reports Medicine
Open Access
Published: Aug 2024
3 citations
3 citations
332 days after retraction
Enhancing TRAIL-based Therapy for Glioblastoma Through Combining the Constitutive TRAIL-Secreting Induced Neural Stem Cells with the Novel Small Molecule Anti-Cancer Drug TR-107
Morrent Thang, Clara Mellows, Lauren Kass et al. (10 authors)
Deleted Journal
Open Access
Published: Jun 2024
1 citation
1 citation
285 days after retraction
Construction of an uricase/catalase/curcumin-co-loaded drug delivery system and its effect on hyper-uric acid-induced kidney injury
Yang Zhang, Xiaobo Li, Chunling Liang et al. (13 authors)
Smart Materials in Medicine
Open Access
Published: Jun 2024
3 citations
3 citations
276 days after retraction
TRIB3 As an Emerging Biomarker and Potential Target for Cholangiocarcinoma: Evidence from Experiments and Bioinformatics
Chen Shen, Yijie Jiao, Yuping Lai et al. (12 authors)
Research Square (Research Square)
Open Access
Published: Mar 2024
2 citations
2 citations
191 days after retraction
TRAIL receptors as prognostic markers and survival predictors in ovarian cancer: A systematic review of clinical studies and meta-analysis
Luciana Maria Silva, Kedma Anne Lima Gomes, Paula Calaça et al. (4 authors)
Revista Colombiana de Ciencias Químico Farmacéuticas
Open Access
Published: Mar 2024
182 days after retraction
Pro-Inflammatory Activation Suppresses TRAIL-induced Apoptosis of Acute Myeloid Leukemia Cells
M. I. Kobyakova, А. С. Сенотов, K. S. Krasnov et al. (12 authors)
Biochemistry (Moscow)
Published: Mar 2024
4 citations
4 citations
179 days after retraction
<scp>ASB3</scp> promotes hepatocellular carcinoma progression by mediating <scp>DR5</scp> ubiquitination in <scp>TRAIL</scp> resistance
Linlin Huang, Zhihui Che, Fuchen Liu et al. (12 authors)
The FASEB Journal
Published: Feb 2024
5 citations
5 citations
158 days after retraction
Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism
Mehrdad Hashem, Elaheh Mohandesi Khosroshahi, Melika Aliahmady et al. (15 authors)
Non-coding RNA Research
Open Access
Published: Jan 2024
3 citations
3 citations
140 days after retraction
Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes
Rongrong Fu, Rui Chang, A Peng et al. (11 authors)
Pharmaceutical Development and Technology
Published: Jan 2024
5 citations
5 citations
120 days after retraction
Novel targeting strategies on signaling pathways of colorectal cancer
Prafulla Sabale, Suchita Waghmare, Lata Potey et al. (8 authors)
Elsevier eBooks
Published: Jan 2024
119 days after retraction
TRAIL-Sensitizing Effects of Flavonoids in Cancer
Ânderson Luiz-Ferreira, Teresa Pacifico, Álefe Cardoso Cruz et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2023
15 citations
15 citations
79 days after retraction
Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells
Rubén López-Cortés, Isabel Correa Pardo, Laura Muinelo‐Romay et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Jul 2023
7 citations
7 citations
41 days before retraction
Ceramides and ceramide synthases in cancer: Focus on apoptosis and autophagy
Javad Alizadeh, Simone C. da Silva Rosa, Xiaohui Weng et al. (12 authors)
European Journal of Cell Biology
Open Access
Published: Jun 2023
46 citations
46 citations
70 days before retraction
Functional enhancement of exosomes derived from NK cells by IL-15 and IL-21 synergy against hepatocellular carcinoma cells: The cytotoxicity and apoptosis in vitro study
In-Young Kim, Ho Yong Kim, Hyeong-woo Song et al. (6 authors)
Heliyon
Open Access
Published: Jun 2023
15 citations
15 citations
95 days before retraction
LncRNAs and regulated cell death in tumor cells
Yingying Wu, Xiao-Ling Wen, Yufang Xia et al. (5 authors)
Frontiers in Oncology
Open Access
Published: May 2023
3 citations
3 citations
98 days before retraction
Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors
Rui Chang, Rongrong Fu, Yujiao Huang et al. (12 authors)
Molecular Pharmaceutics
Published: May 2023
6 citations
6 citations
124 days before retraction
Anti-inflammatory effect and antihepatoma mechanism of carrimycin
Xiuyan Li, Yuting Luo, Yanhong Wang et al. (6 authors)
World Journal of Gastroenterology
Open Access
Published: Apr 2023
6 citations
6 citations
145 days before retraction
Development and clinical application of human mesenchymal stem cell drugs
Yi Liu, Dana T. Graves, Songlin Wang
Science Bulletin
Open Access
Published: Apr 2023
5 citations
5 citations
154 days before retraction
An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma
Peng Wang, Shuya Bai, Mengli Zheng et al. (10 authors)
Translational Oncology
Open Access
Published: Mar 2023
18 citations
18 citations
172 days before retraction
Ran GTPase and Its Importance in Cellular Signaling and Malignant Phenotype
Mohamed El‐Tanani, Hamdi Nsairat, Vijay Mishra et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Feb 2023
29 citations
29 citations
212 days before retraction
Current approaches in enhancing TRAIL therapies in glioblastoma
Morrent Thang, Clara Mellows, Alison R. Mercer-Smith et al. (5 authors)
Neuro-Oncology Advances
Open Access
Published: Jan 2023
11 citations
11 citations
246 days before retraction
Pharmacological Insights into Morin: Therapeutic Applications and Future Perspectives
Fui Fui Lem, Dexter Jiunn Herng Lee, Fong Tyng Chee
Springer eBooks
Published: Jan 2023
5 citations
5 citations
246 days before retraction
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
Manjari Kundu, Yoshimi Endo Greer, Jennifer Dine et al. (4 authors)
Cells
Open Access
Published: Nov 2022
20 citations
20 citations
286 days before retraction
TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment
Régis Brion, Malika Gantier, Kévin Biteau et al. (8 authors)
Cancers
Open Access
Published: Nov 2022
2 citations
2 citations
292 days before retraction
The effect of mesenchymal stem cells and imatinib on macrophage polarization in rat model of liver fibrosis
Ali Malmir, Shirin Farivar, Ramazan Rezaei et al. (7 authors)
Cell Biology International
Published: Oct 2022
4 citations
4 citations
337 days before retraction
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
Daniel S. Green, Franklin Ning, Anna Duemler et al. (29 authors)
Clinical Cancer Research
Open Access
Published: Sep 2022
15 citations
15 citations
356 days before retraction
Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China
Haojie Chen, Jiatong Zhou, Jia Luo et al. (11 authors)
Frontiers in Immunology
Open Access
Published: Aug 2022
8 citations
8 citations
382 days before retraction
Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells
Yunyun Zhang, Panpan Feng, Hongfei Wang et al. (8 authors)
Chemico-Biological Interactions
Published: Aug 2022
12 citations
12 citations
393 days before retraction
A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy
Li Zhao, Tianshan She, Hao Yang et al. (10 authors)
Drug Delivery
Open Access
Published: May 2022
10 citations
10 citations
462 days before retraction
Clinical Impact of 11q13.3 Amplification on Immune Cell Infiltration and Prognosis in Breast Cancer
Renyu Zhou, Xiaoxi Zhu, Yulong Peng et al. (9 authors)
International Journal of General Medicine
Open Access
Published: Apr 2022
12 citations
12 citations
521 days before retraction
Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma
Xiaonan Zhou, Shizhu Guo, Yonghong Shi
Scientific Reports
Open Access
Published: Feb 2022
13 citations
13 citations
563 days before retraction
Astaxanthin Sensitizes Low SOD2-Expressing GBM Cell Lines to TRAIL Treatment via Pathway Involving Mitochondrial Membrane Depolarization
Juhyun Shin, Arti Nile, Ramesh Kumar Saini et al. (4 authors)
Antioxidants
Open Access
Published: Feb 2022
7 citations
7 citations
568 days before retraction
Dietary Carotenoids in Head and Neck Cancer—Molecular and Clinical Implications
Katarzyna Starska
Nutrients
Open Access
Published: Jan 2022
24 citations
24 citations
586 days before retraction
Quick Stats
Total Citations:
41
Years Since Retraction:
2.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025